Myomo (MYO) Total Non-Current Liabilities (2016 - 2025)

Myomo (MYO) reported Total Non-Current Liabilities of $25.6 million for Q4 2025, up 509.38% quarter-over-quarter from $4.2 million in Q3 2021.

Myomo (MYO) Total Non-Current Liabilities (2016 - 2025) Analysis & Trends

Myomo has reported Total Non-Current Liabilities for 7 years, with the latest figure at $25.6 million in Q4 2025.

For the quarter ending Q4 2025, Total Non-Current Liabilities changed N/A year-over-year to $25.6 million; the trailing twelve-month figure through Dec 2025 stood at $25.6 million (changed N/A YoY), and the FY2025 full-year result was $25.6 million, changed N/A from the prior year.
Total Non-Current Liabilities for Q4 2025 stood at $25.6 million, up from $4.2 million in the prior quarter.
The five-year high for Total Non-Current Liabilities was $25.6 million in Q4 2025, with the low at $3.8 million in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Non-Current Liabilities (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	20.94 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	40.52 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	15.78 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	2.44 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	9.85 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	3.53 Bn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	24.21 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	3.47 Bn
10	Myomo	49.44 Mn	31.04 Mn	-	25.58 Mn

Download Data